Dr. Rachel Brem is the Director of Breast Imaging and Intervention at The George Washington University Medical Center, Professor of Radiology and the Vice Chairman of the Department of Radiology. In 2015 Dr. Brem was named the Program Leader for Breast Cancer at the GW Cancer Center. Dr. Brem completed her undergraduate studies at Brandeis University followed by medical school at Columbia University where she graduated with honors. Dr. Brem completed both her Diagnostic Radiology Residency and Breast Imaging Fellowship at the John Hopkins Medical Institutions. Since completion of her training Dr. Brem was on the faulty at John Hopkins as the Director of Breast Imaging. Currently she is the Director of Breast Imaging and Interventional Center at the George Washington Medical Institution and Professor of Radiology. Dr. Brem’s research and clinical interest includes Minimally Invasive Breast Biopsy as well as New Technologies for the Earlier Diagnosis of breast cancer focusing Whole Breast Ultrasound for women with dense breast tissue for improved breast cancer detection and risk assessment, Artificial Intelligence for breast cancer detection and Molecular Imaging of the Breast. She currently directs multi-institutional clinical trials evaluating novel approaches to improved diagnosis of breast cancer and is the recipient of numerous honors and awards including Best Cancer Doctors (Newsweek), Castle Connolly Best Doctors for Cancer and Top Doctor, Jewish Woman International’s Ten Women to Watch, the prestigious fellowship in the American College of Radiology and the Society of Breast Imaging. She is an internationally recognized expert on Breast Cancer who is sought to speak on the subject nationally and internationally. Dr. Brem has extensively published, and is also committed to mentoring of students and residents. She is on the scientific advisory board of The Prevent Cancer Foundation as well as FORCE (Facing our risk of cancer, for women who are BR CA positive) and is a member of the Board of the Katzen Cancer Research Center. She currently serves on the Board of Directors of Delphinus Medical Technologies, Dilon Technologies and Screenpoint Medical. Previously she served on the Board of Directors of iCAD, inc from 2002-2019.
Prior to the Covid pandemic, Dr. Brem was the Director of the George Washington University Mobile Mammography program (Mammovan), a mobile van that brings mammography to underserved communities to optimize the care of all women.
Dr. Brem was part of the formation of the Brem Foundation to Defeat Breast Cancer in 2004 with a group of committed patients and friends who have worked diligently to support risk based breast cancer screening as well as education and clinical care in the underserved community. The Brem Foundation was instrumental in passing dense breast legislation in the District of Columbia which has the highest death rate from cancer nationally.
